The Research Institute

The Research component of the practice, The Research Institute, provides access to the latest National/ International clinical trials on HIV and comorbidities, Hepatitis, Sexually Transmitted Infections, among other. The Institute provides the highest quality of Clinical trials available together with the highest ethical standards in the field. The Medical and non-medical staff involved in trial duties are trained in good clinical practice, and are fully bilingual, cultural-sensitive.

Our Mission

At the forefront of medical progress, our mission is dedicated to granting access to cutting-edge advanced treatments within the realm of Infectious Diseases. We steadfastly strive to deliver unparalleled quality of care and make available the most exceptional treatments presently accessible to our community. Our initiative encompasses both clinical and research facets. The clinical arm of our endeavor is committed to offering personal, discrete, and considerate care tailored to individuals aged 18 and above.

Our services encompass an array of comprehensive offerings, including attentive HIV care, meticulous Hepatitis C and B Care, precise Lyme Disease management, a specialized site for testing and treating Sexually Transmitted Infections, PrEP (HIV prevention), PEP (Post-exposure Prophylaxis), and comprehensive General Infectious Diseases Care.

Dr. Claudia T. Martorell stands as a preeminent figure, having spearheaded more than 75 protocols centered around sexually transmitted infections, PrEP, Hepatitis B, and Hepatitis C, HIV and other infections. For those curious about our ongoing endeavors, we invite you to peruse our active protocols and to stay tuned for regular updates and the emergence of new protocols.

Our Active Protocols

BTZ116577

A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae

Learn More

EMBRACE - 209639

A Phase 2b Multicenter, Randomized, Open-Label Study Comparing the Efficacy, Safety, PK, and Tolerability of VH3810109, Administered Either Intravenously Or As A Subcutaneous Infusion with rHuPH20, in Combination with CAB LA to Standard of Care in Virologically Suppressed Adults Living with HIVDr. Martorell is an Investigator and clinical specialist treating HIV in the United States.

Learn More

TH-IBA-CTR-1003

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab (PROMISE-US). ClinicalTrials.gov ID NCT05388474

M19-965

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of Budigalimab and/or ABBV-382 in People Living with HIV on Stable Antiretroviral Therapy Undergoing Analytical Treatment Interruption

EB-P30-01

A Randomized, Double-Blind, Sham Controlled,Stratified, Pivotal Efficacy and Safety Study of the EmitBio RD-X19 Treatment Device in Individuals 40 Years of Age and Older with Mild COVID-19 in the At-Home Setting (Pro00069215)

Learn More

EMBRACE - 209639

Learn More

HealthyClinic.me

✆ Phone (appointments): 413-747-5566

Address: 57 Mulberry Street, Springfield, MA 01105